UNIQUE GENETIC AND EPIGENETIC ALTERATIONS IN GLIOBLASTOMA VERY LONG-TERM SURVIVORS (VLTS): INSIGHTS FROM TWO CLINICAL CASESNEURO-ONCOLOGYIF13.42024-10-170PRE
Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective studyCANCER LETTERSIF10.12024-04-010PRE
How long and how frequent follow-up care should be for lower-grade gliomas? Retrospective study on patients with LGGs at Neurological Institute Besta of MilanJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22021-10-010PRE
Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48BRAINIF11.72014-05-15131OAAI
Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experienceJOURNAL OF NEURO-ONCOLOGYIF3.12013-05-242OAAI
Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL): A new report of an Italian woman and review of the literatureJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22013-03-0119PREAI
The burden of brain tumor: a single-institution study on psychological patterns in caregiversJOURNAL OF NEURO-ONCOLOGYIF3.12011-10-0442PREAI
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experienceJOURNAL OF NEURO-ONCOLOGYIF3.12011-08-2725PREAI
Attenuation of Angiotensin II-Induced Hypertension and Cardiac Hypertrophy in Transgenic Mice Overexpressing a Type 1 Receptor MutantAMERICAN JOURNAL OF HYPERTENSIONIF3.12009-12-0111OAAI
Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas系统性sagopilone (zk-epo) 治疗复发性恶性神经胶质瘤患者JOURNAL OF NEURO-ONCOLOGYIF3.12009-10-0121PREAI
Cisplatinum and BCNU chemotherapy in primary glioblastoma patientsJOURNAL OF NEURO-ONCOLOGYIF3.12009-02-1127PREAI
Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients (vol 87, pg 143, 2008)JOURNAL OF NEURO-ONCOLOGYIF3.12008-05-170OA
Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?JOURNAL OF NEURO-ONCOLOGYIF3.12008-02-1941PREAI
Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patientsJOURNAL OF NEURO-ONCOLOGYIF3.12007-06-1934PREAI
Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experienceJOURNAL OF NEURO-ONCOLOGYIF3.12006-11-1716PREAI
Systemic temozolomide combined with loco-regional mitoxantrone in treating recurrent glioblastomaJOURNAL OF NEURO-ONCOLOGYIF3.12005-11-0123PREAI
IMPAIRED CARDIOVASCULAR REFLEXES IN CLUSTER HEADACHE AND MIGRAINE PATIENTS - EVIDENCE FOR AN AUTONOMIC DYSFUNCTIONHEADACHEIF42005-06-2243PREAI
Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastomaJOURNAL OF NEURO-ONCOLOGYIF3.12005-04-0127PREAI
Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution studyJOURNAL OF NEURO-ONCOLOGYIF3.12005-02-0117PREAI
Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patientsJOURNAL OF NEURO-ONCOLOGYIF3.12004-01-0165PREAI